Trials / Completed
CompletedNCT04640831
Safety of GH001 in Healthy Volunteers
A Phase 1 Dose-ranging Study of GH001 in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- GH Research Ireland Limited · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The aim of the study is to investigate the safety of GH001 (containing 5-methoxy-dimethyltryptamine; 5-MeO-DMT), and its dose-related psychoactive effects in healthy volunteers. The study will evaluate single, ascending doses of GH001 in Part A and an individualized dosing regimen of GH001 in Part B.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 5 Methoxy N,N Dimethyltryptamine | GH001 administered via inhalation |
Timeline
- Start date
- 2019-03-13
- Primary completion
- 2019-10-04
- Completion
- 2019-10-04
- First posted
- 2020-11-23
- Last updated
- 2023-08-15
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT04640831. Inclusion in this directory is not an endorsement.